# Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice

> **NCT07558707** · — · NOT_YET_RECRUITING · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 7000 (estimated)

## Conditions studied

- Peptic Ulcer
- NSAID-Induced Peptic Ulcer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07558707
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-30
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 7000 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07558707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07558707, "Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07558707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*